Trial · NCT07883915
Comparison of the Effectiveness of Motor Imagery Exercises and Suboccipital Myofascial Release Techniques in Nonspecific Chronic Neck Pain
NCT07883915, Not applicable, Not yet recruiting, Ankara Yildirim Beyazıt University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of the Effectiveness of Motor Imagery Exercises and Suboccipital Myofascial Release Techniques in Nonspecific Chronic Neck Pain. Trials, record NCT07883915. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07883915
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of the Effectiveness of Motor Imagery Exercises and Suboccipital Myofascial Release Techniques in Nonspecific Chronic Neck Pain
- NCT number
- NCT07883915
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 51 participants, estimated
- Lead sponsor
- Ankara Yildirim Beyazıt University
- Conditions
- Non-specific Chronic Neck Pain
- Interventions
- Active Exercise, Motor Imagery, Suboccipital Myofascial Release
- First posted
- 2026-10-20
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proprioception | Baseline and week 6 | Measurement will be performed using a dual inclinometer. Joint position sense error will be evaluated. |
| Primary | Pain Pressure Threshold | Baseline and week 6 | The pressure pain threshold will be assessed using an algometer. |
| Primary | Range of Motion (ROM) | Baseline and week 6 | ROM will be assessed using a goniometer. |
| Secondary | Tampa Scale of Kinesiophobia for Kinesiophobia | Baseline and week 6 | Kinesiophobia is assessed using the 17-item Tampa Scale of Kinesiophobia (TSK-17). Each item is scored on a 4-point Likert scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"), resulting in a total score ranging from 17 to 68. Higher scores represent greater fear of movement and physical activity, with scores higher than 37 generally indicating a high level of kinesiophobia. |
| Secondary | Short Form -36 for Quality of Life | Baseline and week 6 | Health-related quality of life is assessed using Short Form (SF-36). Scores are transformed to range from 0 to 100. Higher scores indicate less pain and lower interference of pain with normal daily work and activities. |
| Secondary | Copenhagen Neck Functional Disability Scale for Neck Disability | Baseline and week 6 | Neck-specific functional disability is assessed using the Copenhagen Neck Functional Disability Scale (CNFDS). The scale consists of 15 items divided into three sub-dimensions evaluating pain during movement, daily activities, and social/recreational activities. Each item is scored on a 3-point scale from 0 to 2 (0 = yes, 1 = sometimes, 2 = no, adjusted for positive/negative item phrasing), yielding a total score ranging from 0 to 30. Higher scores indicate greater neck functional disability and worse health-related status. |
| Secondary | Short-form McGill Pain Questionnaire for Pain Intensity | Baseline and week 6 | Pain intensity and quality are assessed using the Short-Form McGill Pain Questionnaire (SF-MPQ). The questionnaire consists of 15 descriptors (11 sensory and 4 affective items), each rated on an intensity scale from 0 ("none") to 3 ("severe"). The SF-MPQ also includes a 100-mm Visual Analog Scale (VAS) for pain and the Present Pain Intensity (PPI) index. The total SF-MPQ score is calculated by summing the item intensities, ranging from 0 to 45, where higher scores indicate greater pain intensity and a more severe overall pain experience. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07883915
GET https://conductscience.org/api/trials/v1/NCT07883915/registered